EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 42 filers reported holding EVELO BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 14 | -90.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 144 | -93.7% | 0.00% | – |
| Q1 2022 | $7,000 | -82.5% | 2,271 | -66.0% | 0.00% | – |
| Q4 2021 | $40,000 | +73.9% | 6,679 | +102.6% | 0.00% | – |
| Q3 2021 | $23,000 | -20.7% | 3,296 | +58.5% | 0.00% | – |
| Q2 2021 | $29,000 | +61.1% | 2,079 | +23.7% | 0.00% | – |
| Q1 2021 | $18,000 | +38.5% | 1,681 | +55.8% | 0.00% | – |
| Q4 2020 | $13,000 | – | 1,079 | +2469.0% | 0.00% | – |
| Q3 2020 | $0 | – | 42 | +121.1% | 0.00% | – |
| Q2 2020 | $0 | – | 19 | -88.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 163 | -87.9% | 0.00% | – |
| Q4 2019 | $5,000 | +400.0% | 1,343 | +685.4% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 171 | +242.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 50 | -78.1% | 0.00% | – |
| Q3 2018 | $3,000 | – | 228 | +1800.0% | 0.00% | – |
| Q2 2018 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |